The deleterious role of the prostaglandin E2 EP3 receptor in angiotensin II hypertension.

American Journal of Physiology. Heart and Circulatory Physiology
Timothy D BrysonPamela Harding

Abstract

Angiotensin II (ANG II) plays a key role in regulating blood pressure and inflammation. Prostaglandin E2 (PGE2) signals through four different G protein-coupled receptors, eliciting a variety of effects. We reported that activation of the EP3 receptor reduces cardiac contractility. More recently, we have shown that overexpression of the EP4 receptor is protective in a mouse myocardial infarction model. We hypothesize in this study that the relative abundance of EP3 and EP4 receptors is a major determinant of end-organ damage in the diseased heart. Thus EP3 is detrimental to cardiac function and promotes inflammation, whereas antagonism of the EP3 receptor is protective in an ANG II hypertension (HTN) model. To test our hypothesis, male 10- to 12-wk-old C57BL/6 mice were anesthetized with isoflurane and osmotic minipumps containing ANG II were implanted subcutaneously for 2 wk. We found that antagonism of the EP3 receptor using L798,106 significantly attenuated the increase in blood pressure with ANG II infusion. Moreover, antagonism of the EP3 receptor prevented a decline in cardiac function after ANG II treatment. We also found that 10- to 12-wk-old EP3-transgenic mice, which overexpress EP3 in the cardiomyocytes, have worsene...Continue Reading

References

Jan 1, 1979·Pharmacology & Therapeutics·J D Swales
Jan 1, 1992·Annual Review of Physiology·K M BakerD E Dostal
Aug 1, 1990·The American Journal of Physiology·K M Baker, J F Aceto
May 1, 1988·The American Journal of Physiology·C P Bolter, K J Atkinson
Sep 1, 1972·Circulation Research·F E DorerL T Skeggs
Oct 14, 1994·Biochemical and Biophysical Research Communications·A IrieM Negishi
Jan 1, 1996·Advances in Experimental Medicine and Biology·G M CiuffoJ M Saavedra
Sep 24, 1996·Biochemical and Biophysical Research Communications·J A KimJ L Nadler
Jan 1, 1997·Annual Review of Physiology·J Sadoshima, S Izumo
Apr 10, 1997·The New England Journal of Medicine·P J Barnes, M Karin
Sep 24, 1998·The American Journal of Physiology·R H RitchieJ D Marsh
Mar 15, 2000·Journal of the American College of Cardiology·A M FeldmanC McTiernan
Mar 17, 2000·Circulation Research·K K GriendlingM Ushio-Fukai
Feb 13, 2001·Kidney International·C Guijarro, J Egido
Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Jun 1, 2002·Journal of Biochemistry·Noriyuki HataeAtsushi Ichikawa
Mar 29, 2003·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Masahisa Asano, Yukiko Nomura
Apr 5, 2003·The International Journal of Biochemistry & Cell Biology·Yusuke SuzukiJesus Egido
Jun 25, 2003·Journal of the American College of Cardiology·Christophe HeymesAjay M Shah
Aug 19, 2003·British Journal of Pharmacology·Winnie W C ShumYasuharu Sasaki
Oct 29, 2003·Circulation·Kathy K Griendling, Garret A FitzGerald
Dec 13, 2003·American Journal of Physiology. Heart and Circulatory Physiology·Margot C LaPointeXiao-Ping Yang
Apr 21, 2005·The Journal of Clinical Investigation·Steven D CrowleyThomas M Coffman

❮ Previous
Next ❯

Methods Mentioned

BETA
dissection
scraping
ELISArray
enzyme-linked immunosorbent assay
ELISA

Software Mentioned

ImageJ
LabScribe
NIH ImageJ
SAS

Related Concepts

Related Feeds

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.